Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?

MLA

Tamari, R., et al. “Allo-SCT for Myelofibrosis: Reversing the Chronic Phase in the JAK Inhibitor Era?” Bone Marrow Transplantation, vol. 50, no. 5, May 2015, pp. 628–36. EBSCOhost, https://doi.org/10.1038/bmt.2014.323.

APA

Tamari, R., Mughal, T. I., Rondelli, D., Hasserjian, R., Gupta, V., Odenike, O., Fauble, V., Finazzi, G., Pane, F., Mascarenhas, J., Prchal, J., Giralt, S., & Hoffman, R. (2015). Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? Bone Marrow Transplantation, 50(5), 628–636. https://doi.org/10.1038/bmt.2014.323

Chicago

Tamari, R, T I Mughal, D Rondelli, R Hasserjian, V Gupta, O Odenike, V Fauble, et al. 2015. “Allo-SCT for Myelofibrosis: Reversing the Chronic Phase in the JAK Inhibitor Era?” Bone Marrow Transplantation 50 (5): 628–36. doi:10.1038/bmt.2014.323.